Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Human Adipose-Derived CD146(+) Stem Cells Increase Life Span of a Muscular Dystrophy Mouse Model More Efficiently than Mesenchymal Stromal Cells

Full text
Author(s):
Gomes, Juliana P. [1] ; Coatti, Giuliana C. [1] ; Valadares, Marcos C. [1] ; Assoni, Amanda F. [1] ; Pelatti, Mayra V. [1] ; Secco, Mariane [1] ; Zatz, Mayana [1]
Total Authors: 7
Affiliation:
[1] Univ Sao Paulo, Inst Biosci, Human Genome & Stem Cell Res Ctr, Rua Matao, 106 Cidade Univ, BR-05508090 Sao Paulo, SP - Brazil
Total Affiliations: 1
Document type: Journal article
Source: DNA AND CELL BIOLOGY; v. 37, n. 9, p. 798-804, SEP 2018.
Web of Science Citations: 0
Abstract

Duchenne muscular dystrophy is the most common and severe form of progressive muscular dystrophy. Previous results showed an increased survival in double knockout mice (dko) when treated with adipose-derived CD146(+) cells. In this study, we analyzed the effect of CD146(+) cells compared to mesenchymal stem/stromal cells (MSCs) derived from the same human adipose sample when injected in the dko mouse model without immunosuppression. Both CD146(+) cells and MSCs increased the survival of treated mice when compared to vehicle-injected mice, with a more prominent effect of CD146(+) cells than MSCs. Both CD146(+) cells and MSCs suppressed peripheral blood mononuclear cell proliferation, indicating immunomodulatory properties. Co-culture experiments showed that MSCs have a more inflammatory profile expression, and angiogenesis assay showed that CD146(+) cells can improve blood vessel formation. CD146(+) cells can extend survival of muscular dystrophy mice more efficiently than MSCs, possibly due to immunomodulatory and angiogenic properties. Further investigations focusing on exogenous CD146(+) cell role in vivo will improve cell therapy understanding and effectiveness. (AU)

FAPESP's process: 13/08028-1 - CEGH-CEL - Human Genome and Stem Cell Research Center
Grantee:Mayana Zatz
Support type: Research Grants - Research, Innovation and Dissemination Centers - RIDC